News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ernst & Young LLP Announces Lupin Pharmaceuticals, Inc., CEO Vinita Gupta is the Entrepreneur Of The Year® 2012 Award winner in Maryland



7/9/2012 7:42:19 AM

BALTIMORE, July 6, 2012 /PRNewswire/ -- Ernst & Young LLP today announced that Ms. Vinita Gupta, CEO of Lupin Pharmaceuticals, Inc., received the Ernst & Young Entrepreneur Of The Year® 2012 Award in the Health Services and Technology category in Maryland. The award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities. Vinita was selected by an independent panel of judges, and the award was presented at a special gala on June 28, 2012 at the Baltimore Marriott Waterfront.

Commenting on the award, Vinita Gupta, CEO, LPI said, "I am honored to receive this recognition on behalf of our company. We have been very fortunate to have multiple opportunities to grow and differentiate our organization while bringing quality, affordable generics and valuable brands to the US market. The passion, dedication and entrepreneurial spirit of our team has set us apart from competition." Headquartered in Baltimore, Lupin Pharmaceuticals, Inc. (LPI) is a specialty pharmaceutical company delivering high quality branded and generic formulations in the United States.

Now in its 26th year, the Ernst & Young Entrepreneur Of The Year Program has honored the inspirational leadership of such entrepreneurs as Jeff Bezos of Amazon.com, Michael Dell of Dell Inc., Herb Kelleher of Southwest Airlines, Fred Smith of FedEx, Larry Page and Sergey Brin of Google, Richard Schulze of Best Buy, Andrew Mason of Groupon, Mindy Grossman of HSN, Inc., Reid Hoffman and Jeff Weiner of LinkedIn, and many more.

As a Maryland award winner, Vinita is now eligible for consideration for the National Entrepreneur Of The Year 2012 Award. Award winners in several national categories, as well as the National Entrepreneur Of The Year Overall Award winner, will be announced at the annual awards gala in Palm Springs, California, on November 17, 2012. The awards are the culminating event of the Ernst & Young Strategic Growth Forum®, the nation's most prestigious gathering of high-growth, market-leading companies.

Sponsors

Founded and produced by Ernst & Young LLP, the Entrepreneur Of The Year Awards are nationally sponsored in the United States by SAP America and the Ewing Marion Kauffman Foundation. In Maryland, sponsors include the Baltimore Business Journal, DLA Piper, PNC, SmartCEO, Cassidy Turley, ClearView Consulting, and The Mergis Group.

About Lupin Pharmaceuticals, Inc.

Headquartered in Baltimore, MD, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across US & Europe. With revenues exceeding USD 500 million, LPI is the 5th largest and amongst the fastest growing generic pharmaceutical players in the US (by prescriptions). For further information or queries, please contact -

Shamsher Gorawara
Head Corporate Communications
Lupin Limited:
Ph: +91 98 20 338 555
Email: shamshergorawara@lupinpharma.com

About Ernst & Young Entrepreneur Of The Year®

Ernst & Young Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs. The unique award makes a difference through the way it encourages entrepreneurial activity among those with potential, and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 140 cities in more than 50 countries.

About Ernst & Young

Ernst & Young is a global leader in assurance, tax, transaction and advisory services. Worldwide, our 152,000 people are united by our shared values and an unwavering commitment to quality. We make a difference by helping our people, our clients and our wider communities achieve their potential.

Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit www.ey.com.

This news release has been issued by Ernst & Young LLP, a US client-serving member firm of Ernst & Young Global Limited.

SOURCE Lupin Pharmaceuticals, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES